Aspire Biopharma Holdings, Inc.
ASBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $95 | $529 | $529 |
| - Cash | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 |
| Enterprise Value | $96 | $529 | $529 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$12 | -$0 | -$1 |
| % Margin | – | – | – |
| Net Income | -$13 | -$0 | -$1 |
| % Margin | – | – | – |
| EPS Diluted | -0.26 | -0.008 | -0.013 |
| % Growth | -3,233.3% | 40% | – |
| Operating Cash Flow | -$2 | -$1 | -$0 |
| Capital Expenditures | $0 | -$0 | -$5 |
| Free Cash Flow | -$2 | -$1 | -$5 |